Evidence map›Paper›PMID 36246540›Full record

ArticleHealth and technology2022

Predictive analytics of COVID-19 cases and tourist arrivals in ASEAN based on covid-19 cases.

Shubashini Rathina Velu, Vinayakumar Ravi, Kayalvily Tabianan

Abstract read
In one paragraph

Article in Health and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shubashini Rathina VeluPrince Mohammad Bin Fahd University, Khobar, Saudi Arabia.
Vinayakumar RaviCenter for Artificial Intelligence, Prince Mohammad Bin Fahd University, Khobar, Saudi Arabia.ORCID 0000-0001-6873-6469
Kayalvily TabiananFaculty of Information Technology, Inti International University, Persiaran Perdana BBN Putra Nilai, 71800 Nilai, Negeri Sembilan Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Research into predictive analytics, which helps predict future values using historical data, is crucial. In order to foresee future instances of COVID-19, a method based on the Seasonal ARIMA (SARIMA) model is proposed here. Additionally, the suggested model is able to predict tourist arrivals in the tourism business by factoring in COVID-19 during the pandemic. In this paper, we present a model that uses time-series analysis to predict the impact of a pandemic event, in this case the spread of the Coronavirus pandemic (Covid-19). Methods: The proposed approach outperformed the Autoregressive Integrated Moving Average (ARIMA) and Holt Winters models in all experiments for forecasting future values using COVID-19 and tourism datasets, with the lowest mean absolute error (MAE), mean absolute percentage error (MAPE), mean squared error (MSE), and root mean squared error (RMSE). The SARIMA model predicts COVID-19 and tourist arrivals with and without the COVID-19 pandemic with less than 5% MAPE error. Results: The suggested method provides a dashboard that shows COVID-19 and tourism-related information to end users. The suggested tool can be deployed in the healthcare, tourism, and government sectors to monitor the number of COVID-19 cases and determine the correlation between COVID-19 cases and tourism. Conclusion: Management in the tourism industries and stakeholders are expected to benefit from this study in making decisions about whether or not to keep funding a given tourism business. The datasets, codes, and all the experiments are available for further research, and details are included in the appendix.

Indexed as

COVID-19Predictive analyticsRegression modelsTourism

Identifiers

PMID36246540
PMCPMC9546420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.